Acitretin monotherapy in acrodermatitis continua Hallopeau
van Dooren-Greebe RJ, van de Kerkhof PC, Chang A, Happle R.
DOI: 10.2340/0001555569344346
Abstract
In a patient affected with acrodermatitis continua Hallopeau, acitretin (Ro 10-1670) monotherapy resulted in a complete clearance of pustulation at a dosage of 45 mg per day. At this dosage the leukotriene B4-induced intraepidermal accumulation of polymorphonuclear leukocytes was markedly inhibited.
Significance
Supplementary content
Comments